Clinical Success Rates for Male Patients with Complicated Urinary Tract Infection
| Levofloxacin | Ciprofloxacin | P Value | |
|---|---|---|---|
| EOT | |||
| mITT | 87/105 (83%) | 92/119 (77%) | .321 |
| ME | 79/91 (87%) | 84/98 (86%) | .837 |
| Post-Therapy | |||
| mITT | 80/105 (76%) | 93/119 (78%) | .752 |
| ME | 74/91 (81%) | 84/98 (86%) | .438 |
EOT, end of therapy; ME, microbiologically evaluable; mITT, modified intent-to-treat.